BlackRock Institutional Trust’s Lifecore Biomedical LFCR Stock Holding History

BlackRock Institutional Trust’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$11.5M	Buy	834,759 +13,866	+2%	+$192K	﹤0.01%	2317
2016 Q3	$11M	Buy	820,893 +6,769	+0.8%	+$82K	﹤0.01%	2284
2016 Q2	$8.76M	Buy	814,124 +46	+0%	+$507	﹤0.01%	2367
2016 Q1	$8.55M	Sell	814,078 -7,743	-0.9%	-$85K	﹤0.01%	2365
2015 Q4	$9.72M	Sell	821,821 -8,693	-1%	-$107K	﹤0.01%	2341
2015 Q3	$9.69M	Sell	830,514 -68,216	-8%	-$904K	﹤0.01%	2321
2015 Q2	$13M	Sell	898,730 -38,690	-4%	-$558K	﹤0.01%	2236
2015 Q1	$13.1M	Buy	937,420 +2,032	+0.2%	+$28.1K	﹤0.01%	2221
2014 Q4	$12.9M	Sell	935,388 -26,099	-3%	-$337K	﹤0.01%	2205
2014 Q3	$11.8M	Buy	961,487 +98,280	+11%	+$1.23M	﹤0.01%	2224
2014 Q2	$10.8M	Buy	863,207 +19,963	+2%	+$235K	﹤0.01%	2392
2014 Q1	$9.41M	Buy	843,244 +16,315	+2%	+$179K	﹤0.01%	2457
2013 Q4	$10M	Buy	826,929 +16,180	+2%	+$193K	﹤0.01%	2418
2013 Q3	$9.89M	Buy	810,749 +9,810	+1%	+$137K	﹤0.01%	2368
2013 Q2	$10.6M	Buy	+800,939	New	+$11.1M	﹤0.01%	2279

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust's LFCR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Lifecore Biomedical (LFCR) stake by 1.7% in Q4 2016, buying an estimated $192K and bringing the position to 834,759 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

BlackRock Institutional Trust first reported a position in LFCR in Q2 2013 and has held it in 15 quarters since. The position peaked at $13.1M in Q1 2015. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2016.

BlackRock Institutional Trust held 834,759 shares of Lifecore Biomedical worth $11.5M as of Q4 2016.
BlackRock Institutional Trust bought 13,866 Lifecore Biomedical shares in Q4 2016, an estimated $192K.
Lifecore Biomedical made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2317 holding.
BlackRock Institutional Trust first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Lifecore Biomedical position peaked at $13.1M in Q1 2015.
93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.